From: Pharmacokinetics and safety of liposomal bupivacaine after local infiltration in healthy Chinese adults: a phase 1 study
Adverse event
Participant, n (%)
Event, n
Any
15 (75)
22
Any TEAE
Mild
21
Moderate
1 (5)
1
Any TRAE